4-03-2026, 05:00

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Notified -
Globe Newswire4-03-2026, 05:00
19-11-2025, 15:00

Quantexa Named as a Category Leader in Chartis Research’s 2025 AML Transaction Monitoring and KYC Solutions Reports

Notified -
Globe Newswire19-11-2025, 15:00
16-06-2025, 19:30

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Notified -
Globe Newswire16-06-2025, 19:30
19-02-2025, 04:30

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

Notified -
Globe Newswire19-02-2025, 04:30
19-02-2025, 04:30

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

Notified -
Globe Newswire19-02-2025, 04:30
28-02-2023, 11:50

Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies
Globe Newswire28-02-2023, 11:50